Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Galipeau

Showing results (41-50 of 193) with videos related to

Pageof 20
Sort By:
Tissue Engineering. Part A|August 29, 2020
Washed Equine Platelet Extract as an Anti-Inflammatory Biologic PharmaceuticalAndrea Pennati, Taylor Apfelbeck, Sabrina Brounts, et al.
Blood|November 19, 2005
Interferon-gamma-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cellJohn Stagg, Sandra Pommey, Nicoletta Eliopoulos, et al.
Journal of the American Society of Nephrology : JASN|May 5, 2006
Erythropoietin delivery by genetically engineered bone marrow stromal cells for correction of anemia in mice with chronic renal failureNicoletta Eliopoulos, Raymonde F Gagnon, Moira Francois, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 22, 2011
Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiationMoïra François, Raphaëlle Romieu-Mourez, Mengyang Li, et al.
Cancer Research|December 18, 2004
Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapyJohn Stagg, Jian Hui Wu, Nathaniel Bouganim, et al.
Virology Journal|April 11, 2006
Inhibition of histone deacetylation in 293GPG packaging cell line improves the production of self-inactivating MLV-derived retroviral vectorsDiana E Jaalouk, Milena Crosato, Pnina Brodt, et al.
Cellular & Molecular Immunology|January 9, 2018
Adoptive transfer of IL-10<sup>+</sup> regulatory B cells decreases myeloid-derived macrophages in the central nervous system in a transgenic amyotrophic lateral sclerosis modelAndrea Pennati, Seneshaw Asress, Jonathan D Glass, et al.
Virology Journal|November 23, 2006
A self-inactivating retrovector incorporating the IL-2 promoter for activation-induced transgene expression in genetically engineered T-cellsDiana E Jaalouk, Laurence Lejeune, Clément Couture, et al.
Stem Cells (Dayton, Ohio)|August 26, 2006
Cooperation of matrix metalloproteinases with the RhoA/Rho kinase and mitogen-activated protein kinase kinase-1/extracellular signal-regulated kinase signaling pathways is required for the sphingosine-1-phosphate-induced mobilization of marrow-derived stromal cellsMayya Meriane, Stéphanie Duhamel, Laurence Lejeune, et al.
Cytotherapy|April 23, 2013
Immunological characterization of multipotent mesenchymal stromal cells--The International Society for Cellular Therapy (ISCT) working proposalMauro Krampera, Jacques Galipeau, Yufang Shi, et al.
Pageof 20

Showing results (41-50 of 193) with videos related to

Sort By:
Pageof 20
Tissue Engineering. Part A|August 29, 2020
Washed Equine Platelet Extract as an Anti-Inflammatory Biologic PharmaceuticalAndrea Pennati, Taylor Apfelbeck, Sabrina Brounts, et al.
Blood|November 19, 2005
Interferon-gamma-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cellJohn Stagg, Sandra Pommey, Nicoletta Eliopoulos, et al.
Journal of the American Society of Nephrology : JASN|May 5, 2006
Erythropoietin delivery by genetically engineered bone marrow stromal cells for correction of anemia in mice with chronic renal failureNicoletta Eliopoulos, Raymonde F Gagnon, Moira Francois, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 22, 2011
Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiationMoïra François, Raphaëlle Romieu-Mourez, Mengyang Li, et al.
Cancer Research|December 18, 2004
Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapyJohn Stagg, Jian Hui Wu, Nathaniel Bouganim, et al.
Virology Journal|April 11, 2006
Inhibition of histone deacetylation in 293GPG packaging cell line improves the production of self-inactivating MLV-derived retroviral vectorsDiana E Jaalouk, Milena Crosato, Pnina Brodt, et al.
Cellular & Molecular Immunology|January 9, 2018
Adoptive transfer of IL-10<sup>+</sup> regulatory B cells decreases myeloid-derived macrophages in the central nervous system in a transgenic amyotrophic lateral sclerosis modelAndrea Pennati, Seneshaw Asress, Jonathan D Glass, et al.
Virology Journal|November 23, 2006
A self-inactivating retrovector incorporating the IL-2 promoter for activation-induced transgene expression in genetically engineered T-cellsDiana E Jaalouk, Laurence Lejeune, Clément Couture, et al.
Stem Cells (Dayton, Ohio)|August 26, 2006
Cooperation of matrix metalloproteinases with the RhoA/Rho kinase and mitogen-activated protein kinase kinase-1/extracellular signal-regulated kinase signaling pathways is required for the sphingosine-1-phosphate-induced mobilization of marrow-derived stromal cellsMayya Meriane, Stéphanie Duhamel, Laurence Lejeune, et al.
Cytotherapy|April 23, 2013
Immunological characterization of multipotent mesenchymal stromal cells--The International Society for Cellular Therapy (ISCT) working proposalMauro Krampera, Jacques Galipeau, Yufang Shi, et al.
Pageof 20